Allan M. Fox - 17 Sep 2021 Form 4 Insider Report for REGENXBIO Inc. (RGNX)

Role
Director
Signature
/s/ Patrick J. Christmas as attorney-in-fact
Issuer symbol
RGNX
Transactions as of
17 Sep 2021
Net transactions value
-$2,172,323
Form type
4
Filing time
21 Sep 2021, 16:15:08 UTC
Previous filing
08 Jun 2021
Next filing
27 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGNX Common Stock Sale $2,172,323 -48,233 -3.4% $45.04 1,364,309 17 Sep 2021 By DING LLC F1, F2
holding RGNX Common Stock 315,000 17 Sep 2021 By HBF Gift Trust LLC F2
holding RGNX Common Stock 278,541 17 Sep 2021 By Fox 2020 Trust F2
holding RGNX Common Stock 315,000 17 Sep 2021 By AMF Gift Trust LLC F2
holding RGNX Common Stock 722,485 17 Sep 2021 By AMF Family Gift Trust LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $45.00 to $45.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.